Ligand · H05
H05 · 5-propyl[1,2,4]triazolo[1,5-c]quinazolin-2-amine
H05, 5-propyl[1,2,4]triazolo[1,5-c]quinazolin-2-amine (C12 H13 N5, 227.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the…
- Component
- H05
- Formula
- C12 H13 N5
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
H05 in 2 structures; the first of them:
- 4CWF · Human HSP90 alpha N-terminal domain in complex with an Aminotriazoloquinazoline inhibitor · H05 A1224 · binds ASN51, MET98, LEU103, LEU107, ALA111, GLY135, VAL136, PHE138 and 3 more
- 4CWF · Human HSP90 alpha N-terminal domain in complex with an aminotriazoloquinazoline inhibitor · H05 A1224 · binds ASN51, MET98, LEU103, LEU107, ALA111, GLY135, VAL136, PHE138 and 3 more
Residues it binds most
LEU 2, VAL 2, ALA 2, ASN 2, GLY 2, MET 2, PHE 2, TRP 2, TYR 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.